CD47 and gastric cancer: In contrast, an alternative investigation has revealed no statistically substantial variation in CD47 mRNA levels between primary gastric cancer and healthy tissues, thereby concluding that CD47 in primary gastric tumors does not exhibit any correlation with clinicopathological factors or prognosis [47].